Trial Profile
Assessement of efficacy of abatacept treatment in juvenile idiopathic arthritis associated uveitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 31 Aug 2016 New trial record